Profil
Sen Lin Liu is currently Executive General Manager at Shanghai Zhongjin Capital Investment Co. Ltd. Former positions include Non-Executive Director at Sinomab Bioscience Ltd. from 2019 to 2022 and Non-Executive Director at Jiangxi Rimag Group Co. Ltd. from 2021 to 2026.
Education includes an undergraduate degree conferred in 2006 and a graduate degree conferred in 2008, both from Tsinghua University.
Postes actifs de Sen Lin Liu
| Sociétés | Poste | Début |
|---|---|---|
Shanghai Zhongjin Capital Investment Co. Ltd.
Shanghai Zhongjin Capital Investment Co. Ltd. Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
Anciens postes connus de Sen Lin Liu
| Sociétés | Poste | Fin |
|---|---|---|
| JIANGXI RIMAG GROUP CO., LTD. | Directeur/Membre du Conseil | 23/04/2026 |
| SINOMAB BIOSCIENCE LIMITED | Directeur/Membre du Conseil | 28/04/2022 |
Formation de Sen Lin Liu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Zhongjin Capital Investment Co. Ltd.
Shanghai Zhongjin Capital Investment Co. Ltd. Investment ManagersFinance Acts as an alternative investment manager | Finance |
Sinomab Bioscience Ltd.
Sinomab Bioscience Ltd. BiotechnologyHealth Technology Manufactures and distributes antibodies | Health Technology |
Jiangxi Rimag Group Co. Ltd.
Jiangxi Rimag Group Co. Ltd. Financial ConglomeratesFinance Engages in investment and operation of medical imaging centers | Finance |
















